Mon. May 25th, 2026
Spread the love

Scientists at the Redeemer’s University, Nigeria, have said that the Kingdom’s ‘lineage B.1.1.7,’ a mutant variant of the COVID-19 global pandemic, is already in Nigeria.

 

 

 

According to them, the ‘lineage B.1.1.7’ mutant variant of the coronavirus had been existing in Osun State since August 3, 2020, when they obtained the first sample.

 

 

 

They also said that the collection of another sample from the state in October, and it also showed the presence of this new variant.

 

 

 

The ‘lineage B.1.1.7’ variant of COVID-19 has recently become a source of concern in the United Kingdom, leading to another round of lockdown, PUNCH Health Wise reports.

 

 

 

The RUN study, first published last September 6 in The Conversation, a copyright-free news channel, stated that genome sequencing helped researchers to understand the virus, its epidemiology and evolution.

 

 

 

More recently, the finding was also published online in peer-reviewed Journal of Virological Methods on Monday, December 21, and titled, ‘Detection of the New Emergent SARS-CoV-2 Variant in Nigeria.

 

 

 

The study was carried out by two scientists at Ede, Osun State-based RUN — Professor of Molecular Biology and Genomics, Christian Happi; and Ify Aniebo.

 

 

 

 

 

 

 

The researchers are of the African Centre of Excellence for the Genomics of Infectious Diseases at the RUN’s Ede campus.

 

 

 

They worked in collaboration with the Nigeria Centre for Disease Control and had reported 24 additional genome sequences of the COVID-19 from Nigeria.

 

 

 

Last week, the UK had reported a more virulent strain of COVID-19, with the potential to infect by 70 percent.

 

 

 

 

 

 

 

The B.1.1.7 variant of the virus, thought to be a mutation associated with higher transmission and pathogenicity, is the latest scourge in the United Kingdom and has made the British government to declare another lockdown to check its spread.

 

 

 

A handful of countries have also banned flights from the UK in order to prevent its importation into their countries.

 

 

 

Prof. Happi, in The Conversation article, said globally, there is only one strain of SARS-CoV-2, which is also the same as the strain circulating in Nigeria, noting, however, that there are more than 1,000 lineages of this novel virus in circulation around the world.

 

 

 

While identifying the root of the pandemic, the researchers said many sequences originating from China and many global exports — including to South East Asia, Japan, South Korea, Australia, the USA and Europe — are represented in this lineage.

 

 

 

More crucially, the researchers said the B.1 strain of COVID-19 was of a large European lineage that corresponds to the Italian outbreak.

 

 

 

They added that the B.2.1 strain was of a large lineage with representation from the UK, Europe, Jordan, Australia, USA, India, and Ghana.

 

 

 

Talking about their findings, the scientists said, “We investigated the presence of the globally spread spike protein mutation D614G which has steadily increased temporally in Europe, East coast of the United States, South America,

 

 

 

Africa and some parts of Asia, and found four Nigerian patients infected with the Spike D614G mutant virus.”

 

 

 

Continuing, they said, “Three of these patients presented with very severe disease.

 

 

 

“This mutation has been associated with higher transmission and pathogenicity, and also helps the virus to evade immune interventions as it dominates the wild type whenever it is introduced into a new location.”

 

 

 

According to the RUNS researchers, only about one percent of the genomes from Nigeria belong to the mutant B.1.1.7 lineage and that one of them predated the UK experience.

 

 

 

Stressing the importance of their findings, the researchers said, “Inasmuch as the full effect of this mutation is still being studied, the importance of a robust genomic surveillance system cannot be overemphasised, as we can identify and report changes in the genomes of pathogens such as SARS-CoV-2 that are of public health interest.”

 

 

 

Speaking about the UK COVID-19 strain in the House of Commons last week, Britain’s Secretary of Health, Matt Hancock, said the new variant of coronavirus might be associated with the faster spread in the south-east of England.

 

 

 

British Prime Minister, Boris Johnson, also said the new strain of coronavirus could be “up to 70 per cent more transmissible” than the earlier one.

 

 

 

Again, on Monday, a lady, Jenny Dissents, on Twitter @StilettoKitten alleged that the new strain of COVID-19 in the UK had blinded her brother.

 

 

 

The RUN scientists, however, noted that, “The lineages identified in Nigeria are not different from the ones identified in other parts of the world and there are no reports of strains or lineages unique to Nigeria thus far.”

 

 

 

Discussing the implications of COVID-19 mutation, they said, “For instance, a virus with an advantageous mutation could affect humans more readily, thereby spreading more easily between people; it could be less recognised by the immune system, or more pathogenic [causing disease].

 

“If a mutation occurs in the region of the virus that was used to develop the vaccine, the vaccine will not be as effective. This is what happens in the case of flu vaccines because the virus keeps mutating into a new strain.”

 

As of the time they made their findings public last September 6, the scientists had warned, “We do not know much about SARS-CoV-2 yet. And we don’t know if the virus will mutate into a new strain down the line.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.